Health · 29 Oct
క్యాన్సర్ మందుల ధరలకు బ్రేక్ పడలేదా? సుప్రీంకోర్టు ఆదేశించినా మారని 37 ఔషధాల ధరలు!
AI summaryAccording to the National Pharmaceutical Pricing Authority (NPPA), 37 out of 543 listed cancer drugs have not had their prices reduced despite the Supreme Court's directives. Health experts noted that merely limiting trade margins offers minimal relief and suggested the government implement compulsory licensing to curb high prices.
1 outlet · 1 loaded term flagged